The Global Genes Next 2021 Report: A Time for Resilience and Ingenuity, written by Daniel Levine is complete and available from Global Genes. The report covers major developments of 2020 and the top trends that are reshaping the rare disease landscape. Click the link below to access the report.
Related
Global Genes 2022 RARE Impact Grants Report
Over the past decade, Global Genes’ RARE Impact Grant Program has provided funding opportunities for rare patient […]
Read moreRARE-X Insights & Recommendations for Organizational DEI Strategies Study
Ensuring diversity, equity, and inclusion in rare disease organizations requires focused programs that engage all stakeholders. A […]
Read moreRARE Health Equity Report: Building a More Inclusive Rare Disease Community
For communities of color and other minoritized populations, finding and connecting with others in their disease community, […]
Read more2022 Rare Disease Drug Development Report: Collaborate to Accelerate
In June 2022, Global Genes partnered with the Orphan Drug Center of the University of Pennsylvania to […]
Read more2019 NEXT: Imagining the Future of Rare Disease
The pace of innovation continues to accelerate, thanks in no small measure to the growing sophistication of […]
Read moreRARE Drug Development 2020 Report
RARE Drug Development Report This year began with hope for the future and advancements in rare […]
Read moreGlobal Genes Impact Report: Building on a Successful 2022
To our community members: The year 2022 was a significant one for the rare disease community as […]
Read moreNEXT 2023: The Rise of the Impatient Advocate
As Global Genes begins the year with an expanded focus on enabling next-generation patient advocacy, following its […]
Read moreNEXT 2022 – Redefining the Possible
Download your free copy of NEXT 2022. This report forecasts the developments, trends, and the progress being […]
Read more